搜索医生

John M. Davis, III, M.D.

  1. Internist
  2. Rheumatologist
预约门诊

出版物

  1. Shakhashiro M, Sadeghian S, Newcomer J, Marzano AV, Maronese CA, Davis JM 3rd, Alavi A. Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations. Int J Dermatol. 2024 Jul 4 Epub 2024 July 04
    View PubMed
  2. Vassilaki M, Jose George R, Kumar R, Lovering E, Achenbach SJ, Bielinski SJ, St Sauver J, Davis JM 3rd, Crowson CS, Myasoedova E. Validation of Different Dementia Code-based Definitions in a Population-based Study of Rheumatoid Arthritis. J Rheumatol. 2024 Jul 1 Epub 2024 July 01
    View PubMed
  3. Stevens MA, Dykhoff HJ, Kronzer VL, Myasoedova E, Davis JM 3rd, Duarte-Garcia A, Crowson CS. Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan. Rheumatology (Oxford). 2024 May 3; 63 (6):1639-1648
    View PubMed
  4. Williamson KA, Yun M, Koster MJ, Arment C, Patnaik A, Chang TW, Bledsoe AC, Sae-Tia S, Shah AS, Samuels J, Davis JM 3rd, Yao Q. Susceptibility of nucleotide-binding oligomerization domain 2 mutations to Whipple's disease. Rheumatology (Oxford). 2024 May 2; 63 (5):1291-1296
    View PubMed
  5. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2024 Apr 30; 22 (1):400
    View PubMed
  6. Crowson CS, Atkinson EJ, Kronzer VL, Kimbrough BA, Arment CA, Peterson LS, Wright K, Mason TG 2nd, Bekele DI, Davis JM 3rd, Myasoedova E. Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis. Ann Rheum Dis. 2024 Apr 11; 83 (5):556-563
    View PubMed
  7. Kimbrough BA, Crowson CS, Lennon RJ, Davis JM 3rd, Strangfeld A, Myasoedova E. Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2024 Apr; 65:152386 Epub 2024 Jan 15
    View PubMed
  8. Kimbrough BA, Crowson CS, Davis JM 3rd, Matteson EL, Myasoedova E. Decline in Incidence of Extra-Articular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study. Arthritis Care Res (Hoboken). 2024 Apr; 76 (4):454-462 Epub 2023 Dec 10
    View PubMed
  9. Karmacharya P, Crowson CS, Lennon RJ, Poudel D, Davis JM 3rd, Ogdie A, Liew JW, Ward MM, Ishimori M, Weisman MH, Brown MA, Rahbar MH, Hwang MC, Reveille JD, Gensler LS. Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohort. Semin Arthritis Rheum. 2024 Feb; 64:152282 Epub 2023 Nov 07
    View PubMed
  10. Peterson MN, Giblon RE, Achenbach SJ, Davis JM 3rd, TerKonda SP, Crowson CS. The Incidence and Outcomes of Breast Implants Among 1696 Women over more than 50 Years. Aesthetic Plast Surg. 2023 Dec; 47 (6):2268-2276 Epub 2023 Aug 14
    View PubMed
  11. Montes D, Hulshizer CA, Myasoedova E, Davis JM 3rd, Hanson AC, Duarte-Garcia A, Figueroa-Parra G, Chevet B, Crowson CS. Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort. RMD Open. 2023 Nov; 9 (4)
    View PubMed
  12. Mousa J, Peterson MN, Crowson CS, Achenbach SJ, Atkinson EJ, Amin S, Khosla S, Davis JM 3rd, Myasoedova E. Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid Arthritis. J Rheumatol. 2023 Oct; 50 (10):1279-1286 Epub 2023 July 01
    View PubMed
  13. Chang YH, Buras MR, Davis JM 3rd, Crowson CS. Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated Measures. J Rheumatol. 2023 Oct; 50 (10):1269-1272 Epub 2023 May 15
    View PubMed
  14. Balakrishnan B, Luckey D, Wright K, Davis JM, Chen J, Taneja V. Eggerthella lenta augments preclinical autoantibody production and metabolic shift mimicking senescence in arthritis. Sci Adv. 2023 Sep; 9(35):eadg1129.
    View PubMed
  15. Crowson LP, Davis JM 3rd, Hanson AC, Myasoedova E, Kronzer VL, Makol A, Peterson LS, Bekele DI, Crowson CS. Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018. Semin Arthritis Rheum. 2023 Aug; 61:152219 Epub 2023 May 05
    View PubMed
  16. Myasoedova E, Kurmann RD, Achenbach SJ, Wright K, Arment CA, Dunlay SM, Davis JM 3rd, Crowson CS. Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure Definitions. J Rheumatol. 2023 Jul; 50 (7):881-888 Epub 2023 Mar 15
    View PubMed
  17. Pinto E Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM 3rd, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM, Lazaridis KN. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2023 Jun 23; 21(1):410.
    View PubMed
  18. Cunningham KY, Hur B, Gupta VK, Arment CA, Wright KA, Mason TG, Peterson LS, Bekele DI, Schaffer DE, Bailey ML, Delger KE, Crowson CS, Myasoedova E, Zeng H, Rodriguez M, Weyand CM, Davis JM 3rd, Sung J. Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity. Sci Rep. 2023 Apr 1; 13 (1):5360 Epub 2023 Apr 01
    View PubMed
  19. Kronzer VL, Kimbrough BA, Crowson CS, Davis JM 3rd, Holmqvist M, Ernste FC. Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-Based Cohort Study. Arthritis Care Res (Hoboken). 2023 Feb; 75 (2):348-355 Epub 2022 Oct 06
    View PubMed
  20. Crowson CS, Gunderson TM, Davis JM 3rd, Myasoedova E, Kronzer VL, Coffey CM, Atkinson EJ. Using Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-Based Cohort of Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2023 Feb; 75 (2):210-219 Epub 2022 Sept 15
    View PubMed
  21. Kronzer VL, Hayashi K, Yoshida K, Davis JM 3rd, McDermott GC, Huang W, Dellaripa PF, Cui J, Feathers V, Gill RR, Hatabu H, Nishino M, Blaustein R, Crowson CS, Robinson WH, Sokolove J, Liao KP, Weinblatt ME, Shadick NA, Doyle TJ, Sparks JA. Autoantibodies against citrullinated and native proteins and prediction of rheumatoid arthritis-associated interstitial lung disease: A nested case-control study. Lancet Rheumatol. 2023 Feb; 5 (2):e77-e87 Epub 2023 Jan 24
    View PubMed
  22. Kodishala C, Hulshizer CA, Kronzer VL, Davis JM 3rd, Ramanan VK, Vassilaki M, Mielke MM, Crowson CS, Myasoedova E. Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study. J Rheumatol. 2023 Jan; 50 (1):48-55 Epub 2022 July 15
    View PubMed
  23. Kronzer VL, Dykhoff HJ, Stevens MA, Myasoedova E, Davis JM 3rd, Crowson CS. Racial Differences in Multimorbidity and Comorbidities in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2023 Jan; 75 (1):76-84 Epub 2022 Oct 31
    View PubMed
  24. Gupta VK, Bakshi U, Chang D, Lee AR, Davis JM 3rd, Chandrasekaran S, Jin YS, Freeman MF, Sung J. TaxiBGC: a Taxonomy-Guided Approach for Profiling Experimentally Characterized Microbial Biosynthetic Gene Clusters and Secondary Metabolite Production Potential in Metagenomes. mSystems. 2022 Dec 20; 7 (6):e0092522 Epub 2022 Nov 15
    View PubMed
  25. Samhouri BF, Vassallo R, Achenbach SJ, Kronzer VL, Davis JM 3rd, Myasoedova E, Crowson CS. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort. Arthritis Care Res (Hoboken). 2022 Dec; 74 (12):2042-2049 Epub 2022 Aug 10
    View PubMed
  26. Kronzer VL, Davis JM 3rd, Crowson CS. Epidemiologic Opportunities and Challenges in Studying Environmental Risk Factors for Rheumatic Diseases. Rheum Dis Clin North Am. 2022 Nov; 48 (4):763-779 Epub 2022 Oct 01
    View PubMed
  27. Heckman MG, Davis JM 3rd, Crowson CS. Post Hoc Power Calculations: An Inappropriate Method for Interpreting the Findings of a Research Study. J Rheumatol. 2022 Aug; 49 (8):867-870 Epub 2022 Feb 01
    View PubMed
  28. Duong SQ, Crowson CS, Athreya A, Atkinson EJ, Davis JM 3rd, Warrington KJ, Matteson EL, Weinshilboum R, Wang L, Myasoedova E. Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data. Arthritis Res Ther. 2022 Jul 1; 24 (1):162 Epub 2022 July 01
    View PubMed
  29. Myasoedova E, Athreya AP, Crowson CS, Davis JM 3rd, Warrington KJ, Walchak RC, Carlson E, Kalari KR, Bongartz T, Tak PP, van Vollenhoven RF, Padyukov L, Emery P, Morgan A, Wang L, Weinshilboum RM, Matteson EL, Pharmacogenetics of Methotrexate in Rheumatoid Arthritis Consortium. Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach. Arthritis Care Res (Hoboken). 2022 Jun; 74 (6):879-888 Epub 2022 Apr 06
    View PubMed
  30. Kronzer VL, Huang W, Zaccardelli A, Crowson CS, Davis JM 3rd, Vassallo R, Doyle TJ, Losina E, Sparks JA. Association of Sinusitis and Upper Respiratory Tract Diseases With Incident Rheumatoid Arthritis: A Case-control Study. J Rheumatol. 2022 Apr; 49 (4):358-364 Epub 2021 Oct 15
    View PubMed
  31. Myasoedova E, Davis JM 3rd, Kronzer VL, Giblon RE, Atkinson EJ, LeBrasseur NK, Crowson CS. The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study. Semin Arthritis Rheum. 2022 Feb; 52:151941 Epub 2021 Dec 31
    View PubMed
  32. Challener GJ, Myasoedova E, Crowson CS, Giblon RE, Atkinson EJ, Davis JM 3rd. Body mass index trend and variability in rheumatoid arthritis. Clin Rheumatol. 2022 Feb; 41 (2):349-355 Epub 2021 Sept 11
    View PubMed
  33. O'Neill KD, Marks KE, Sinicrope PS, Crowson CS, Symons D, Myasoedova E, Davis JM 3rd. Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis-A Cross-Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve When Goals Are Discussed. ACR Open Rheumatol. 2021 Dec; 3 (12):870-878 Epub 2021 Sept 18
    View PubMed
  34. Bansal P, Goyal A, Cusick A 4th, Lahan S, Dhaliwal HS, Bhyan P, Bhattad PB, Aslam F, Ranka S, Dalia T, Chhabra L, Sanghavi D, Sonani B, Davis JM 3rd. Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019. Ann Med. 2021 Dec; 53 (1):117-134
    View PubMed
  35. Gunderson TM, Myasoedova E, Davis JM 3rd, Crowson CS. Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study. J Rheumatol. 2021 Nov; 48 (11):1648-1654 Epub 2021 Feb 15
    View PubMed
  36. Wilton KM, Achenbach SJ, Davis JM 3rd, Myasoedova E, Matteson EL, Crowson CS. Erectile Dysfunction and Cardiovascular Risk in Men With Rheumatoid Arthritis: A Population-based Cohort Study. J Rheumatol. 2021 Nov; 48 (11):1641-1647 Epub 2021 Jan 15
    View PubMed
  37. Karmacharya P, Crowson CS, Bekele D, Achenbach SJ, Davis JM 3rd, Ogdie A, Duarte-Garcia A, Ernste FC, Maradit-Kremers H, Tollefson MM, Wright K. The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based Study. Arthritis Rheumatol. 2021 Oct; 73 (10):1878-1885 Epub 2021 Aug 14
    View PubMed
  38. Peterson MN, Dykhoff HJ, Crowson CS, Davis JM 3rd, Sangaralingham LR, Myasoedova E. Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study. Arthritis Res Ther. 2021 Sep 18; 23 (1):244 Epub 2021 Sept 18
    View PubMed
  39. Gupta VK, Cunningham KY, Hur B, Bakshi U, Huang H, Warrington KJ, Taneja V, Myasoedova E, Davis JM 3rd, Sung J. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. Genome Med. 2021 Sep 14; 13 (1):149 Epub 2021 Sept 14
    View PubMed
  40. Myasoedova E, Davis JM, Roger VL, Achenbach SJ, Crowson CS. Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study. J Rheumatol. 2021 Sep; 48 (9):1379-1387 Epub 2021 Feb 15
    View PubMed
  41. Karmacharya P, Wright K, Achenbach SJ, Bekele D, Crowson CS, Ogdie A, Duarte-Garcia A, Ernste FC, Tollefson MM, Davis JM. Diagnostic Delay in Psoriatic Arthritis: A Population-based Study. J Rheumatol. 2021 Sep; 48 (9):1410-1416 Epub 2021 Feb 15
    View PubMed
  42. Kronzer VL, Crowson CS, Davis JM 3rd, Vassilaki M, Mielke MM, Myasoedova E. Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study. Semin Arthritis Rheum. 2021 Aug; 51 (4):853-857 Epub 2021 June 15
    View PubMed
  43. Hur B, Gupta VK, Huang H, Wright KA, Warrington KJ, Taneja V, Davis JM 3rd, Sung J. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity. Arthritis Res Ther. 2021 Jun 8; 23 (1):164 Epub 2021 June 08
    View PubMed
  44. Paknikar SS, Crowson CS, Davis JM, Thanarajasingam U. Exploring the Role of Antinuclear Antibody Positivity in the Diagnosis, Treatment, and Health Outcomes of Patients With Rheumatoid Arthritis. ACR Open Rheumatol. 2021 Jun; 3 (6):422-426 Epub 2021 May 31
    View PubMed
  45. Kronzer VL, Huang W, Dellaripa PF, Huang S, Feathers V, Lu B, Iannaccone CK, Gill RR, Hatabu H, Nishino M, Crowson CS, Davis JM 3rd, Weinblatt ME, Shadick NA, Doyle TJ, Sparks JA. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. J Rheumatol. 2021 May; 48 (5):656-663 Epub 2020 Nov 15
    View PubMed
  46. Kronzer VL, Davis JM 3rd. Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis. Curr Rheumatol Rep. 2021 Mar 1; 23 (4):21 Epub 2021 Mar 01
    View PubMed
  47. Kronzer VL, Bridges SL Jr, Davis JM 3rd. Why women have more autoimmune diseases than men: An evolutionary perspective. Evol Appl. 2021 Mar; 14 (3):629-633 Epub 2020 Dec 01
    View PubMed
  48. Myasoedova E, Karmacharya P, Duarte-Garcia A, Davis JM 3rd, Murad MH, Crowson CS. Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020 Dec; 50 (6):1348-1356 Epub 2020 Apr 09
    View PubMed
  49. Liu Y, Jaquith JM, Mccarthy-Fruin K, Zhu X, Zhou X, Li Y, Crowson C, Davis JM 3rd, Thanarajasingam U, Zeng H. Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritis. Clin Rheumatol. 2020 Dec; 39 (12):3631-3637 Epub 2020 May 30
    View PubMed
  50. Davis JM 3rd, Myasoedova E, Gunderson TM, Crowson CS. Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort. Rheumatol Ther. 2020 Dec; 7 (4):979-991 Epub 2020 Oct 28
    View PubMed
  51. Karmacharya P, Shahukhal R, Crowson CS, Murad MH, Davis JM 3rd, Shrestha P, Bekele D, Wright K, Chakradhar R, Dubreuil M. Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis. Rheumatol Ther. 2020 Dec; 7 (4):993-1009 Epub 2020 Nov 10
    View PubMed
  52. Kronzer VL, Tarabochia AD, Lobo Romero AS, Tan NY, O'Byrne TJ, Crowson CS, Turley TN, Myasoedova E, Davis JM 3rd, Raphael CE, Gulati R, Hayes SN, Tweet MS. Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease. J Am Coll Cardiol. 2020 Nov 10; 76(19):2226-2234.
    View PubMed
  53. Gupta VK, Kim M, Bakshi U, Cunningham KY, Davis JM 3rd, Lazaridis KN, Nelson H, Chia N, Sung J. A predictive index for health status using species-level gut microbiome profiling. Nat Commun. 2020 Sep 15; 11 (1):4635 Epub 2020 Sept 15
    View PubMed
  54. Davis JM 3rd. Overview of the Associations Between Cancer and Rheumatic Disease. Rheum Dis Clin North Am. 2020 Aug; 46 (3):417-427 Epub 2020 June 07
    View PubMed
  55. Kunchok A, Aksamit AJ Jr, Davis JM 3rd, Kantarci OH, Keegan BM, Pittock SJ, Weinshenker BG, McKeon A. Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events. JAMA Neurol. 2020 Aug 1; 77 (8):937-946
    View PubMed
  56. Wang F, Sun L, Wang S, Davis JM 3rd, Matteson EL, Murad MH, Luo F, Vassallo R. Efficacy and Safety of Tofacitinib, Baricitinib, and Upadacitinib for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Mayo Clin Proc. 2020 Jul; 95 (7):1404-1419 Epub 2020 June 01
    View PubMed
  57. Karmacharya P, Duarte-Garcia A, Dubreuil M, Murad MH, Shahukhal R, Shrestha P, Myasoedova E, Crowson CS, Wright K, Davis JM 3rd. Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2020 May; 72 (5):733-749 Epub 2020 Apr 01
    View PubMed
  58. Myasoedova E, De Thurah A, Erpelding ML, Schneeberger EE, Maribo T, Citera G, Davis JM, Matteson EL, Crowson CS, Fautrel B, Guillemin F. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire. Semin Arthritis Rheum. 2020 Apr; 50 (2):261-265 Epub 2019 Sept 11
    View PubMed
  59. Davis JM 3rd, Crowson CS, Knutson KL, Achenbach SJ, Strausbauch MA, Therneau TM, Matteson EL, Gabriel SE, Wettstein PJ. Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation. Clin Immunol. 2020 Feb; 211:108342 Epub 2020 Jan 08
    View PubMed
  60. Myasoedova E, Davis JM 3rd, Matteson EL, Achenbach SJ, Setoguchi S, Dunlay SM, Roger VL, Gabriel SE, Crowson CS. Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population. Semin Arthritis Rheum. 2020 Feb; 50 (1):25-29 Epub 2019 July 15
    View PubMed
  61. Challa DNV, Kvrgic Z, Crowson CS, Matteson EL, Mason TG, Michet CJ Jr, Schaffer DE, Wright KA, Davis JM 3rd. Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case-Control Study. Arthritis Care Res (Hoboken). 2020 Jan; 72 (1):18-26 Epub 2019 Dec 10
    View PubMed
  62. Wampler Muskardin TL, Fan W, Jin Z, Jensen MA, Dorschner JM, Ghodke-Puranik Y, Dicke B, Vsetecka D, Wright K, Mason T, Persellin S, Michet CJ, Davis JM 3rd, Matteson E, Niewold TB. Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis. Front Immunol. 2020; 11:1384 Epub 2020 July 16
    View PubMed
  63. Coffey CM, Davis JM 3rd, Crowson CS. The impact of gender on time to rheumatoid arthritis classification: a retrospective analysis of a population-based cohort. Rheumatol Int. 2019 Dec; 39 (12):2025-2030 Epub 2019 July 23
    View PubMed
  64. Richter MD, Matteson EL, Davis JM 3rd, Achenbach SJ, Crowson CS. Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis. ACR Open Rheumatol. 2019 Dec; 1 (10):627-631 Epub 2019 Oct 26
    View PubMed
  65. Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis JM 3rd. Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis. Mayo Clin Proc. 2019 Dec; 94 (12):2488-2498 Epub 2019 Nov 20
    View PubMed
  66. Myasoedova E, Crowson CS, Giblon RE, McCarthy-Fruin K, Schaffer DE, Wright K, Matteson EL, Davis JM 3rd. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial. Clin Rheumatol. 2019 Nov; 38 (11):3025-3032 Epub 2019 July 01
    View PubMed
  67. Coffey CM, Crowson CS, Myasoedova E, Matteson EL, Davis JM 3rd. Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity. Mayo Clin Proc. 2019 Nov; 94 (11):2241-2248 Epub 2019 Oct 13
    View PubMed
  68. Kronzer VL, Crowson CS, Sparks JA, Vassallo R, Davis JM 3rd. Investigating Asthma, Allergic Disease, Passive Smoke Exposure, and Risk of Rheumatoid Arthritis. Arthritis Rheumatol. 2019 Aug; 71 (8):1217-1224 Epub 2019 July 01
    View PubMed
  69. Davis JM 3rd. Rheumatoid Arthritis: A Severe Disease That Preventive Approaches Would Greatly Benefit. Clin Ther. 2019 Jul; 41 (7):1240-1245 Epub 2019 June 10
    View PubMed
  70. Myasoedova E, Davis JM 3rd, Achenbach SJ, Matteson EL, Crowson CS. Trends in Prevalence of Functional Disability in Rheumatoid Arthritis Compared With the General Population. Mayo Clin Proc. 2019 Jun; 94 (6):1035-1039 Epub 2019 May 01
    View PubMed
  71. Muniz Pedrogo DA, Chen J, Hillmann B, Jeraldo P, Al-Ghalith G, Taneja V, Davis JM 3rd, Knights D, Nelson H, Faubion WA, Raffals L, Kashyap PC. An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study. Inflamm Bowel Dis. 2019 Apr 11; 25 (5):902-913
    View PubMed
  72. Kvrgic Z, Asiedu GB, Crowson CS, Ridgeway JL, Davis JM 3rd. "Like No One Is Listening to Me": A Qualitative Study of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 Oct; 70 (10):1439-1447 Epub 2018 Sept 04
    View PubMed
  73. Wang L, Rastegar-Mojarad M, Ji Z, Liu S, Liu K, Moon S, Shen F, Wang Y, Yao L, Davis Iii JM, Liu H. Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis. Front Pharmacol. 2018; 9:875 Epub 2018 Aug 07
    View PubMed
  74. Challa DN, Kvrgic Z, Cheville AL, Crowson CS, Bongartz T, Mason TG 2nd, Matteson EL, Michet CJ Jr, Persellin ST, Schaffer DE, Muskardin TLW, Wright K, Davis JM 3rd. Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation. Arthritis Res Ther. 2017 Sep 26; 19 (1):212 Epub 2017 Sept 26
    View PubMed
  75. Davis JM 3rd, Lin G, Oh JK, Crowson CS, Achenbach SJ, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE. Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population. Int J Cardiol. 2017 Aug 1; 240:379-385 Epub 2017 Mar 31
    View PubMed
  76. Challa DNV, Crowson CS, Davis JM 3rd. The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors. Rheumatol Ther. 2017 Jun; 4 (1):201-208 Epub 2017 May 09
    View PubMed
  77. Myasoedova E, Gabriel SE, Matteson EL, Davis JM 3rd, Therneau TM, Crowson CS. Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA? J Rheumatol. 2017 Jun; 44 (6):732-739 Epub 2017 Apr 01
    View PubMed
  78. Scanlon EM, Mankad R, Crowson CS, Kullo IJ, Mulvagh SL, Matteson EL, Kvrgic Z, Davis JM 3rd. Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testing. Clin Rheumatol. 2017 Apr; 36 (4):763-771 Epub 2016 Dec 17
    View PubMed
  79. Crowson AD, Colligan RC, Matteson EL, Davis JM 3rd, Crowson CS. Explanatory Style in Patients with Rheumatoid Arthritis: An Unrecognized Predictor of Mortality. J Rheumatol. 2017 Feb; 44 (2):170-173 Epub 2016 Nov 15
    View PubMed
  80. Ungprasert P, Thongprayoon C, Davis JM 3rd. Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis. Clin Rheumatol. 2016 Jul; 35 (7):1795-803 Epub 2016 Feb 06
    View PubMed
  81. Zamora-Legoff JA, Achenbach SJ, Crowson CS, Krause ML, Davis JM 3rd, Matteson EL. Opioid use in patients with rheumatoid arthritis 2005-2014: a population-based comparative study. Clin Rheumatol. 2016 May; 35 (5):1137-44 Epub 2016 Mar 29
    View PubMed
  82. Ungprasert P, Srivali N, Cheungpasitporn W, Davis Iii JM. Risk of incident chronic obstructive pulmonary disease in patients with rheumatoid arthritis: A systematic review and meta-analysis. Joint Bone Spine. 2016 May; 83 (3):290-4 Epub 2015 Dec 18
    View PubMed
  83. Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, Nelson H, Matteson EL, Taneja V. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016 Apr 21; 8 (1):43
    View PubMed
  84. Ungprasert P, Thongprayoon C, Davis JM 3rd. Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis. Semin Arthritis Rheum. 2016 Feb; 45 (4):428-38 Epub 2015 Oct 03
    View PubMed
  85. Jiao J, Davis Iii JM, Cha SS, Luedtke CA, Vincent A, Oh TH. Association of rheumatic diseases with symptom severity, quality of life, and treatment outcome in patients with fibromyalgia. Scand J Rheumatol. 2016 Jan; 45 (1):49-56 Epub 2015 Sept 22
    View PubMed
  86. Bongartz T, Glazebrook KN, Kavros SJ, Murthy NS, Merry SP, Franz WB 3rd, Michet CJ, Veetil BM, Davis JM 3rd, Mason TG 2nd, Warrington KJ, Ytterberg SR, Matteson EL, Crowson CS, Leng S, McCollough CH. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2015 Jun; 74 (6):1072-7 Epub 2014 Mar 25
    View PubMed
  87. Deng X, Crowson CS, Rajkumar SV, Dispenzieri A, Larson DR, Therneau TM, Matteson EL, Kyle RA, Katzmann JA, Gabriel SE, Davis JM 3rd. Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritis. J Rheumatol. 2015 Feb; 42 (2):181-7 Epub 2015 Jan 15
    View PubMed
  88. Krause ML, Crowson CS, Bongartz T, Matteson EL, Michet CJ, Mason TG, Persellin ST, Gabriel SE, Davis JM 3rd. Determinants of Disability in Rheumatoid Arthritis: A Community-Based Cohort Study. Open Rheumatol J. 2015; 9:88-93 Epub 2015 Nov 20
    View PubMed
  89. Venegas-Pont M, Davis JM, Crowson CS, Gabriel SE, Matteson EL. Frequency of radiologic procedures in patients with rheumatoid arthritis. J. clin. rheumatol. 2015 Jan; 21(1):15-8.
    View PubMed
  90. Makol A, Davis JM 3rd, Crowson CS, Therneau TM, Gabriel SE, Matteson EL. Time trends in glucocorticoid use in rheumatoid arthritis: results from a population-based inception cohort, 1980-1994 versus 1995-2007. Arthritis Care Res (Hoboken). 2014 Oct; 66 (10):1482-8
    View PubMed
  91. Crowson CS, Therneau TM, Davis JM 3rd, Roger VL, Matteson EL, Gabriel SE. Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum. 2013 Oct; 65 (10):2562-6
    View PubMed
  92. Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, Hlatky MA, Gabriel SE. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013 Oct; 166 (4):622-628.e1 Epub 2013 Aug 29
    View PubMed
  93. Myasoedova E, Davis JM 3rd, Crowson CS, Roger VL, Karon BL, Borgeson DD, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum. 2013 Jul; 65 (7):1713-8
    View PubMed
  94. Crowson CS, Matteson EL, Davis JM 3rd, Gabriel SE. Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Jan; 65 (1):71-7
    View PubMed
  95. Davis JM, Knutson KL, Strausbauch MA, Green AB, Crowson CS, Therneau TM, Matteson EL, Gabriel SE. Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity. Arthritis Res Ther. 2013; 15(6):R199.
    View PubMed
  96. Davis JM 3rd, Matteson EL, American College of Rheumatology//European League Against Rheumatism. My treatment approach to rheumatoid arthritis. Mayo Clin Proc. 2012 Jul; 87 (7):659-73
    View PubMed
  97. Davis JM 3rd, Knutson KL, Skinner JA, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis. Arthritis Res Ther. 2012 Jan 31; 14 (1):R24
    View PubMed
  98. Krause ML, Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis. Clin Immunol. 2011 Oct; 141 (1):67-72 Epub 2011 May 30
    View PubMed
  99. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol. 2011 Aug; 38 (8):1601-6 Epub 2011 May 15
    View PubMed
  100. Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Roger VL, Matteson EL, Gabriel SE. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum. 2011 Jun; 63 (6):1497-506
    View PubMed
  101. Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken). 2011 May; 63 (5):729-34
    View PubMed
  102. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar; 63 (3):633-9
    View PubMed
  103. Krause ML, Davis JM, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Corrigendum to "Assessing immune function by profiling cytokine release from stimulated blood leukocytes and the risk of infection in rheumatoid arthritis" [Clin. Immunol. 141 (2011) 67-72]. Clin Immunol. 2011; 141(3):372.
  104. Crowson CS, Myasoedova E, Davis JM 3rd, Matteson EL, Roger VL, Therneau TM, Fitz-Gibbon P, Rodeheffer RJ, Gabriel SE. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol. 2011 Jan; 38 (1):29-35 Epub 2010 Oct 15
    View PubMed
  105. Myasoedova E, Davis JM 3rd, Crowson CS, Gabriel SE. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep. 2010 Oct; 12 (5):379-85
    View PubMed
  106. Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, Borgeson DD, Therneau TM, Rodeheffer RJ, Gabriel SE. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis. 2010 Sep; 69 (9):1665-70 Epub 2010 May 24
    View PubMed
  107. Davis JM 3rd, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol. 2010 Jun 15; 184 (12):7297-304 Epub 2010 May 21
    View PubMed
  108. Davis JM 3rd, Matteson EL. [Not Available]. Reumatol Clin. 2009 Jul-Aug; 5 (4):143-6 Epub 2009 May 08
    View PubMed
  109. Davis JM III, Matteson EL. Cytokine biomarkers and the promise of personalized therapy in rheumatoid. [Spanish]. Reumatologia Clinica. 2009; 5(4):143-6.
  110. Davis JM 3rd, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum. 2008 Sep; 58 (9):2603-11
    View PubMed
  111. Gonzalez A, Icen M, Kremers HM, Crowson CS, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol. 2008 Jun; 35(6):1009-14. Epub 2008 Apr 15.
    View PubMed
  112. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum. 2007 Nov; 56 (11):3583-7
    View PubMed
  113. Maradit Kremers H, Reinalda MS, Crowson CS, Davis JM 3rd, Hunder GG, Gabriel SE. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum. 2007 Mar 15; 57(2):279-86.
    View PubMed
  114. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2007 Mar; 56 (3):820-30
    View PubMed
  115. Davis JM 3rd, Moder KG, Homburger HA, Ytterberg SR. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases. Medicine (Baltimore). 2005 Jul; 84 (4):208-217
    View PubMed
PST-20224282